Shrihari S Kadkol

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. pmc Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis
    Shrihari S Kadkol
    Departments of Pathology, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    J Mol Diagn 6:22-7. 2004
  2. ncbi request reprint MLL-SEPT6 fusion transcript with a novel sequence in an infant with acute myeloid leukemia
    Shrihari S Kadkol
    Department of Pathology, University of Illinois Medical Center at Chicago, Chicago, IL 60612, USA
    Cancer Genet Cytogenet 168:162-7. 2006
  3. doi request reprint Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma
    Xianyong Gui
    Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
    Peptides 29:1609-15. 2008
  4. pmc Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study
    Shrihari S Kadkol
    Department of Pathology, University of Illinois at Chicago, 60612, USA
    Invest Ophthalmol Vis Sci 47:802-6. 2006
  5. pmc pp32 reduction induces differentiation of TSU-Pr1 cells
    Jonathan R Brody
    Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    Am J Pathol 164:273-83. 2004
  6. ncbi request reprint Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin
    Alexander Maret
    Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 89:8-12. 2004
  7. ncbi request reprint Identification of a functional mutation in pp32r1 (ANP32C)
    G John Kochevar
    Department of Pathology, Texas A and M University System Health Science Center, College Station, Texas, USA
    Hum Mutat 23:546-51. 2004
  8. pmc Authenticating cell lines in ophthalmic research laboratories
    Robert Folberg
    Oakland University William Beaumont School of Medicine, Rochester, Michigan 48309 4401, USA
    Invest Ophthalmol Vis Sci 49:4697-701. 2008

Collaborators

  • Valerie Lindgren
  • Xianyong Gui
  • Andrew J Maniotis
  • Jonathan R Brody
  • Robert Folberg
  • G John Kochevar
  • Alexander Maret
  • Gary R Pasternack
  • Klara Valyi-Nagy
  • Jacob Pe'er
  • Martine J Jager
  • Shahar Frenkel
  • Changlin Ding
  • Fatemeh Rajaii
  • William H Westra
  • M Claire Hauer
  • Isabelle Bourdeau
  • Jessica Lee
  • Michael A Levine
  • Kathleen M Murphy

Detail Information

Publications8

  1. pmc Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis
    Shrihari S Kadkol
    Departments of Pathology, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    J Mol Diagn 6:22-7. 2004
    ....
  2. ncbi request reprint MLL-SEPT6 fusion transcript with a novel sequence in an infant with acute myeloid leukemia
    Shrihari S Kadkol
    Department of Pathology, University of Illinois Medical Center at Chicago, Chicago, IL 60612, USA
    Cancer Genet Cytogenet 168:162-7. 2006
    ..The findings emphasize the importance of combined cytogenetic and molecular analyses in the workup of acute leukemia, especially in those leukemias that occur infrequently...
  3. doi request reprint Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma
    Xianyong Gui
    Department of Pathology, University of Illinois at Chicago, Chicago, IL, USA
    Peptides 29:1609-15. 2008
    ..NTSR1 may thus be a potential target for preventive or therapeutic strategies in colon cancer...
  4. pmc Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study
    Shrihari S Kadkol
    Department of Pathology, University of Illinois at Chicago, 60612, USA
    Invest Ophthalmol Vis Sci 47:802-6. 2006
    ..This was a pilot study conducted to examine the expression of osteopontin in uveal melanoma and to determine whether serum osteopontin can be used in detecting metastatic uveal melanoma...
  5. pmc pp32 reduction induces differentiation of TSU-Pr1 cells
    Jonathan R Brody
    Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    Am J Pathol 164:273-83. 2004
    ..Thus, reduction of pp32 in the undifferentiated TSU-Pr1 neoplastic cell line induces differentiation and thus may be an element of a differentiation control pathway in both normal and neoplastic cells...
  6. ncbi request reprint Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin
    Alexander Maret
    Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 89:8-12. 2004
    ..Finally, intrathymic PTH-secreting adenomas express the parathyroid-specific GCMB gene, which suggests that these tumors were derived from parathyroid cells that migrated errantly during embryogenesis...
  7. ncbi request reprint Identification of a functional mutation in pp32r1 (ANP32C)
    G John Kochevar
    Department of Pathology, Texas A and M University System Health Science Center, College Station, Texas, USA
    Hum Mutat 23:546-51. 2004
    ..The pp32r1 mutation could thus be causally associated with the neoplastic growth properties of PC-3, and be of potential clinical significance...
  8. pmc Authenticating cell lines in ophthalmic research laboratories
    Robert Folberg
    Oakland University William Beaumont School of Medicine, Rochester, Michigan 48309 4401, USA
    Invest Ophthalmol Vis Sci 49:4697-701. 2008